Clinical Trial Update: A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020) [Phase 2]

View source ↗

Summary

A Phase 2 study (0777-020) evaluated MK0777 in outpatients with generalized anxiety disorder. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• MK0777 (MK0777)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anxiety Disorders | Phase 2 | Status: COMPLETED